Growth Metrics

Unicycive Therapeutics (UNCY) Operating Leases (2021 - 2026)

Unicycive Therapeutics posted quarterly Operating Leases of $217000.0 for Q1 2026, up 85.47% on a QoQ basis from $117000.0 in Q4 2024.

Unicycive Therapeutics (UNCY) has 5 years of Operating Leases data on file, last reported at $217000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $217000.0; the trailing twelve-month figure through Mar 2026 stood at $217000.0 (changed N/A YoY), and the FY2024 full-year result was $117000.0, down 74.89% from the prior year.
  • Operating Leases for Q1 2026 stood at $217000.0, up from $117000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $800000.0 in Q4 2022 and bottomed at $29000.0 in Q3 2022.
  • The 4-year median for Operating Leases is $274000.0 (2024), against an average of $355923.1.
  • The widest annual swing landed in 2023, when Operating Leases jumped 1803.45%; it then slumped 74.89% in 2024.
  • A 4-year view of Operating Leases shows it stood at $800000.0 in 2022, then plunged by 41.75% to $466000.0 in 2023, then plunged by 74.89% to $117000.0 in 2024, then soared by 85.47% to $217000.0 in 2026.
  • The last three Operating Leases figures came in at $217000.0 (Q1 2026), $117000.0 (Q4 2024), and $265000.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Unicycive Therapeutics 181.94 Mn 127.36 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 217,000.00
Dec 31, 2024 117,000.00
Sep 30, 2024 265,000.00
Jun 30, 2024 274,000.00
Mar 31, 2024 372,000.00
Dec 31, 2023 466,000.00
Sep 30, 2023 552,000.00
Jun 30, 2023 634,000.00
Mar 31, 2023 715,000.00
Dec 31, 2022 800,000.00
Sep 30, 2022 29,000.00
Jun 30, 2022 72,000.00
Mar 31, 2022 114,000.00
Dec 31, 2021 155,000.00